Riparian is discovering new therapeutics to promote vascular health

In nature, the riparian zone is a unique rich ecosystem created through the interaction of a river with its banks.

In the human body, moving blood interacts with the walls of blood vessels generating unique biological activity. This unique flow-sensitive biology is a critical and unexplored determinant of vascular health. Riparian’s therapeutic programs target key vasoprotective pathways to reduce vascular inflammation and endothelial dysfunction, key drivers of many diseases.

IN ITS PURSUIT OF NEW THERAPEUTICS, Riparian:

raised over $10 million in grants and venture financing

leverageS the tremendous resources of the Boston biotech community

COLLABORATES WITH LEADING ACADEMIC LABS AT BRIGHAM & WOMEN’S HOSPITAL